Article Abstract

Is serotonin pathology a good biomarker in vivo for early Parkinson’s disease?

Authors: Celia Painous, Andres Perissinotti, Maria J. Martí


Parkinson’s disease (PD) is a neurodegenerative disorder characterized pathologically by the aggregation of alpha-synuclein (SNCA), which is the main component of Lewy bodies, and the loss of dopaminergic neurons in the substantia nigra (1).

Article Options

Download Citation